159 related articles for article (PubMed ID: 9484402)
1. Lhermitte's sign following chemotherapy with docetaxel.
van den Bent MJ; Hilkens PH; Sillevis Smitt PA; van Raaij-van den Aarssen VJ; Bontenbal M; Verweij J
Neurology; 1998 Feb; 50(2):563-4. PubMed ID: 9484402
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of severe peripheral neuropathy induced by docetaxel (Taxotere).
Hilkens PH; Verweij J; Vecht CJ; Stoter G; van den Bent MJ
Ann Oncol; 1997 Feb; 8(2):187-90. PubMed ID: 9093729
[TBL] [Abstract][Full Text] [Related]
3. Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatin.
Hilkens PH; Pronk LC; Verweij J; Vecht CJ; van Putten WL; van den Bent MJ
Br J Cancer; 1997; 75(3):417-22. PubMed ID: 9020489
[TBL] [Abstract][Full Text] [Related]
4. Combination docetaxel/cyclophosphamide in patients with advanced solid tumors.
Valero V
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):34-6. PubMed ID: 9364540
[TBL] [Abstract][Full Text] [Related]
5. Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trial.
Blaney SM; Seibel NL; O'Brien M; Reaman GH; Berg SL; Adamson PC; Poplack DG; Krailo MD; Mosher R; Balis FM
J Clin Oncol; 1997 Apr; 15(4):1538-43. PubMed ID: 9193350
[TBL] [Abstract][Full Text] [Related]
6. Peripheral neuropathy secondary to docetaxel (Taxotere).
New PZ; Jackson CE; Rinaldi D; Burris H; Barohn RJ
Neurology; 1996 Jan; 46(1):108-11. PubMed ID: 8559355
[TBL] [Abstract][Full Text] [Related]
7. Docetaxel in combination with fluorouracil for advanced solid tumors.
Burris HA
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):50-2. PubMed ID: 9364544
[TBL] [Abstract][Full Text] [Related]
8. Is weekly docetaxel an active and gentle chemotherapy in the treatment of metastatic breast cancer?
Maisano R; Mare M; Zavettieri M; Caristi N; Mesiti M; Scisca C; La Torre F
Anticancer Res; 2003; 23(2C):1923-6. PubMed ID: 12820480
[TBL] [Abstract][Full Text] [Related]
9. A Phase I/II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prognosis squamous cell carcinoma of the head and neck.
Tishler RB; Norris CM; Colevas AD; Lamb CC; Karp D; Busse PM; Nixon A; Frankenthaler R; Lake-Willcutt B; Costello R; Case M; Posner MR
Cancer; 2002 Oct; 95(7):1472-81. PubMed ID: 12237916
[TBL] [Abstract][Full Text] [Related]
10. Docetaxel vs doxorubicin in metastatic breast cancer resistant to alkylating chemotherapy.
Chan S
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):19-24. PubMed ID: 9364537
[TBL] [Abstract][Full Text] [Related]
11. Docetaxel in combination with platinums in patients with advanced non-small-cell lung cancer.
Belani CP
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):42-5. PubMed ID: 9364542
[TBL] [Abstract][Full Text] [Related]
12. Use caution when managing paclitaxel and taxotere infiltrations.
Goodman M; Stewart I; Lydon J; Blendowski C; Barnicle M; Petersen J; Wickham R
Oncol Nurs Forum; 1996 Apr; 23(3):541-2. PubMed ID: 8801516
[No Abstract] [Full Text] [Related]
13. Docetaxel vs mitomycin plus vinblastine in anthracycline-resistant metastatic breast cancer.
Nabholtz JM; Thuerlimann B; Bezwoda WR; Melnychuk D; Deschênes L; Douma J; Vandenberg TA; Rapoport B; Rosso R; Trillet-Lenoir V; Drbal J; Aapro MS; Alaki M; Murawsky M; Riva A
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):25-30. PubMed ID: 9364538
[TBL] [Abstract][Full Text] [Related]
14. Docetaxel as neoadjuvant chemotherapy in patients with stage III breast cancer.
Gradishar WJ
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):15-8. PubMed ID: 9364536
[TBL] [Abstract][Full Text] [Related]
15. A dose escalation study of weekly docetaxel in patients with advanced solid tumors.
Kouroussis C; Agelaki S; Mavroudis D; Souglakos J; Kakolyris S; Kalbakis K; Vardakis N; Reppa D; Hatzidaki D; Samonis G; Georgoulias V
Cancer Chemother Pharmacol; 2000; 46(6):488-92. PubMed ID: 11138462
[TBL] [Abstract][Full Text] [Related]
16. Docetaxel (taxotere) extravasation: a report of five cases with treatment recommendations.
Ascherman JA; Knowles SL; Attkiss K
Ann Plast Surg; 2000 Oct; 45(4):438-41. PubMed ID: 11037169
[TBL] [Abstract][Full Text] [Related]
17. Reversible life-threatening encephalopathy in the absence of hepatic failure following conventional doses of docetaxel.
Guglani S; Farrugia D; Elsdon M; Parmar M; Owen JR
Clin Oncol (R Coll Radiol); 2003 May; 15(3):160-1. PubMed ID: 12801056
[No Abstract] [Full Text] [Related]
18. Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis.
Tomiak E; Piccart MJ; Kerger J; Lips S; Awada A; de Valeriola D; Ravoet C; Lossignol D; Sculier JP; Auzannet V
J Clin Oncol; 1994 Jul; 12(7):1458-67. PubMed ID: 7912725
[TBL] [Abstract][Full Text] [Related]
19. Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer.
Hainsworth JD; Burris HA; Erland JB; Thomas M; Greco FA
J Clin Oncol; 1998 Jun; 16(6):2164-8. PubMed ID: 9626217
[TBL] [Abstract][Full Text] [Related]
20. Docetaxel/doxorubicin/cyclophosphamide in the treatment of metastatic breast cancer.
Nabholtz JM; Smylie M; Mackey JR; Noel D; Paterson AH; al-Tweigeri T; Au D; Sansregret E; Delorme F; Riva A
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):37-41. PubMed ID: 9364541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
